TRIB1 regulates liver regeneration by antagonizing the NRF2-mediated antioxidant response
暂无分享,去创建一个
Ying Chen | Yutong Wang | Xinyue Sun | Zhiwen Fan | Zilong Li | Shuai Wang | Yong Xu | Sheng Zeng | Yan Guo | Fangqiao Lv | Xiulian Miao | Anqi Zhou | Yifei Chen
[1] J. Li,et al. A transcriptomic intratumour heterogeneity-free signature overcomes sampling bias in prognostic risk classification for hepatocellular carcinoma , 2023, JHEP reports : innovation in hepatology.
[2] M. Kamel,et al. Berberine attenuates epithelial mesenchymal transition in bleomycin-induced pulmonary fibrosis in mice via activating A2aR and mitigating the SDF-1/CXCR4 signaling. , 2023, Life sciences.
[3] Luyang Li,et al. Zinc finger transcription factor Egf1 promotes non-alcoholic fatty liver disease , 2023, JHEP reports : innovation in hepatology.
[4] Junxia Xie,et al. Intraperitoneal injection of iron dextran induces peripheral iron overload and mild neurodegeneration in the nigrostriatal system in C57BL/6 mice. , 2023, Life sciences.
[5] Haoming Zhou,et al. TAK1 deficiency promotes liver injury and tumorigenesis via ferroptosis and macrophage cGAS-STING signalling , 2023, JHEP reports : innovation in hepatology.
[6] Zheng Xu,et al. Targetable Brg1‐CXCL14 axis contributes to alcoholic liver injury by driving neutrophil trafficking , 2023, EMBO molecular medicine.
[7] Valinteshley Pierre,et al. Ribonucleosides from tRNA in hyperglycemic mammalian cells and diabetic murine cardiac models , 2023, Life sciences.
[8] Long Chen,et al. Myocardin-related transcription factor A, regulated by serum response factor, contributes to diabetic cardiomyopathy in mice. , 2023, Life sciences.
[9] Wei Zhang,et al. Exosomal LINC00355 promotes the malignant progression of gastric cancer through histone deacetylase HDAC3-mediated TP53INP1 transcriptional inhibition. , 2023, Life sciences.
[10] G. Wang,et al. Small molecule drugs promote repopulation of transplanted hepatocytes by stimulating cell dedifferentiation , 2023, JHEP reports : innovation in hepatology.
[11] Bilian Liu,et al. Cathelicidin promotes liver repair after acetaminophen-induced liver injury in mice , 2023, JHEP reports : innovation in hepatology.
[12] Xiaoyu Liang,et al. BAP31 regulates the expression of ICAM-1/VCAM-1 via MyD88/NF-κB pathway in acute lung injury mice model. , 2023, Life sciences.
[13] Yuyu Yang,et al. MKL1 fuels ROS-induced proliferation of vascular smooth muscle cells by modulating FOXM1 transcription , 2022, Redox biology.
[14] L. Vuillard,et al. Selective disruption of NRF2-KEAP1 interaction leads to NASH resolution and reduction of liver fibrosis in mice , 2022, JHEP reports : innovation in hepatology.
[15] Hua-Guo Xu,et al. NF-κB regulates the expression of STING via alternative promoter usage. , 2022, Life sciences.
[16] M. Pan,et al. Skp2-mediated Zeb1 expression facilitates cancer migration by a ubiquitination-independent pathway. , 2022, Life sciences.
[17] E. Nice,et al. Disrupting metformin adaptation of liver cancer cells by targeting the TOMM34/ATP5B axis , 2022, EMBO molecular medicine.
[18] D. Tweardy,et al. Spatial molecular and cellular determinants of STAT3 activation in liver fibrosis progression in non-alcoholic fatty liver disease , 2022, JHEP reports : innovation in hepatology.
[19] Cheng Huang,et al. Myc-mediated circular RNA circMcph1/miR-370-3p/Irak2 axis is a progressive regulator in hepatic fibrosis. , 2022, Life sciences.
[20] I. Ng,et al. SCYL3, as a novel binding partner and regulator of ROCK2, promotes hepatocellular carcinoma progression , 2022, JHEP reports : innovation in hepatology.
[21] R. Liu,et al. Epigenetic repression of THBD transcription by BRG1 contributes to deep vein thrombosis. , 2022, Thrombosis research.
[22] Zihang Yuan,et al. Obeticholic acid aggravates liver injury by up-regulating the liver expression of osteopontin in obstructive cholestasis. , 2022, Life sciences.
[23] Haoming Zhou,et al. XBP1-mediated activation of the STING signalling pathway in macrophages contributes to liver fibrosis progression , 2022, JHEP reports : innovation in hepatology.
[24] U. Beuers,et al. Systemic ASBT inactivation protects against liver damage in obstructive cholestasis in mice , 2022, JHEP reports : innovation in hepatology.
[25] A. Perrakis,et al. A type IV Autotaxin inhibitor ameliorates acute liver injury and nonalcoholic steatohepatitis , 2022, EMBO molecular medicine.
[26] Zhanjun Jia,et al. Acetaminophen-induced reduction of NIMA-related kinase 7 expression exacerbates acute liver injury , 2022, JHEP reports : innovation in hepatology.
[27] B. Ke,et al. Novel role of macrophage TXNIP-mediated CYLD–NRF2–OASL1 axis in stress-induced liver inflammation and cell death , 2022, JHEP reports : innovation in hepatology.
[28] X. Zou,et al. Trans-activation of eotaxin-1 by Brg1 contributes to liver regeneration , 2022, Cell Death & Disease.
[29] J. Tchorz,et al. The RSPO‐LGR4/5‐ZNRF3/RNF43 module in liver homeostasis, regeneration, and disease , 2022, Hepatology.
[30] T. Luedde,et al. Swelling-induced upregulation of miR-141-3p inhibits hepatocyte proliferation , 2022, JHEP reports : innovation in hepatology.
[31] Chenggang Wu,et al. Tribbles pseudokinase NIPI-3 regulates intestinal immunity in Caenorhabditis elegans by controlling SKN-1/Nrf activity. , 2021, Cell reports.
[32] X. Zhang,et al. TRIB2 desensitizes ferroptosis via βTrCP-mediated TFRC ubiquitiantion in liver cancer cells , 2021, Cell death discovery.
[33] K. Keeshan,et al. Structure vs. Function of TRIB1—Myeloid Neoplasms and Beyond , 2021, Cancers.
[34] F. Bellanti,et al. The Aging Liver: Redox Biology and Liver Regeneration. , 2021, Antioxidants & redox signaling.
[35] L. Mao,et al. Myocardin-related transcription factor A (MRTF-A) regulates integrin beta 2 transcription to promote macrophage infiltration and cardiac hypertrophy in mice. , 2021, Cardiovascular research.
[36] X. Zhang,et al. TRIB2 modulates proteasome function to reduce ubiquitin stability and protect liver cancer cells against oxidative stress , 2021, Cell death & disease.
[37] G. Michalopoulos,et al. Liver regeneration: biological and pathological mechanisms and implications , 2020, Nature Reviews Gastroenterology & Hepatology.
[38] Yingyong Hou,et al. Inhibition of LXR Signaling by SULT2B1b Promotes Liver Regeneration After Partial Hepatectomy in Mouse Models of Nonalcoholic Fatty Liver Disease. , 2020, American journal of physiology. Gastrointestinal and liver physiology.
[39] Rick B. Vega,et al. An improvement in skeletal muscle mitochondrial capacity with short‐term aerobic training is associated with changes in Tribbles 1 expression , 2020, Physiological reports.
[40] S. Nyberg,et al. Understanding the marvels behind liver regeneration , 2019, Wiley interdisciplinary reviews. Developmental biology.
[41] P. Rada,et al. p38α deficiency restrains liver regeneration after partial hepatectomy triggering oxidative stress and liver injury , 2019, Scientific Reports.
[42] Y. Inoue,et al. TRB1 negatively regulates gluconeogenesis by suppressing the transcriptional activity of FOXO1 , 2019, FEBS letters.
[43] P. Kamath,et al. Burden of liver diseases in the world. , 2019, Journal of hepatology.
[44] C. Cummins,et al. Beyond the Foam Cell: The Role of LXRs in Preventing Atherogenesis , 2018, International journal of molecular sciences.
[45] G. Sethi,et al. Antioxidant response elements: Discovery, classes, regulation and potential applications , 2018, Redox biology.
[46] D. Tuveson,et al. Transcriptional Regulation by Nrf2 , 2017, Antioxidants & redox signaling.
[47] P. Eyers,et al. Tribbles in the 21st Century: The Evolving Roles of Tribbles Pseudokinases in Biology and Disease , 2017, Trends in cell biology.
[48] K. Behnia,et al. Beneficial and Adverse Effects of an LXR Agonist on Human Lipid and Lipoprotein Metabolism and Circulating Neutrophils. , 2016, Cell Metabolism.
[49] P. Rada,et al. WNT-3A regulates an Axin1/NRF2 complex that regulates antioxidant metabolism in hepatocytes. , 2015, Antioxidants & redox signaling.
[50] P. Loyer,et al. Glutathione transferases P1/P2 regulate the timing of signaling pathway activations and cell cycle progression during mouse liver regeneration , 2015, Cell Death and Disease.
[51] Masayuki Yamamoto,et al. Loss of Nrf2 in mice evokes a congenital intrahepatic shunt that alters hepatic oxygen and protein expression gradients and toxicity. , 2014, Toxicological sciences : an official journal of the Society of Toxicology.
[52] Chin-Lee Wu,et al. MicroRNA‐224 inhibits progression of human prostate cancer by downregulating TRIB1 , 2014, International journal of cancer.
[53] M. Unno,et al. NF‐E2‐related factor 2 promotes compensatory liver hypertrophy after portal vein branch ligation in mice , 2014, Hepatology.
[54] Jiansheng Huang,et al. Elucidating the metabolic regulation of liver regeneration. , 2014, The American journal of pathology.
[55] R. McPherson,et al. ERK1/2 regulates hepatocyte Trib1 in response to mitochondrial dysfunction. , 2013, Biochimica et biophysica acta.
[56] S. Thorgeirsson,et al. Biphasic regulation of the NADPH oxidase by HGF/c-Met signaling pathway in primary mouse hepatocytes. , 2013, Biochimie.
[57] Xiaotang Fan,et al. LXR Agonists: New Potential Therapeutic Drug for Neurodegenerative Diseases , 2013, Molecular Neurobiology.
[58] Bin Zhang,et al. PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse , 2011, Nucleic Acids Res..
[59] Won Dong Kim,et al. Nrf2 inhibits LXRα-dependent hepatic lipogenesis by competing with FXR for acetylase binding. , 2011, Antioxidants & redox signaling.
[60] Zev Rosenwaks,et al. Inductive angiocrine signals from sinusoidal endothelium are required for liver regeneration , 2010, Nature.
[61] S. Blacklow,et al. Differential ability of Tribbles family members to promote degradation of C/EBPalpha and induce acute myelogenous leukemia. , 2010, Blood.
[62] M. Vacca,et al. Down‐regulation of the LXR transcriptome provides the requisite cholesterol levels to proliferating hepatocytes , 2010, Hepatology.
[63] Donna D. Zhang,et al. Phosphorylation of Nrf2 at Multiple Sites by MAP Kinases Has a Limited Contribution in Modulating the Nrf2-Dependent Antioxidant Response , 2009, PloS one.
[64] Shelly C. Lu,et al. Effects of hepatocyte growth factor on glutathione synthesis, growth, and apoptosis is cell density-dependent. , 2008, Experimental cell research.
[65] P. Bugnon,et al. Impaired liver regeneration in Nrf2 knockout mice: role of ROS‐mediated insulin/IGF‐1 resistance , 2008, The EMBO journal.
[66] D. Ord,et al. TRB3 protects cells against the growth inhibitory and cytotoxic effect of ATF4. , 2007, Experimental cell research.
[67] C. Le Page,et al. Characterization of ovarian cancer ascites on cell invasion, proliferation, spheroid formation, and gene expression in an in vitro model of epithelial ovarian cancer. , 2007, Neoplasia.
[68] N. Fausto,et al. Liver regeneration , 2006, Hepatology.
[69] H. Hayashi,et al. TRB3, a novel ER stress‐inducible gene, is induced via ATF4–CHOP pathway and is involved in cell death , 2005, The EMBO journal.
[70] K. Itoh,et al. Keap1 regulates both cytoplasmic‐nuclear shuttling and degradation of Nrf2 in response to electrophiles , 2003, Genes to cells : devoted to molecular & cellular mechanisms.
[71] M. Fessler. The challenges and promise of targeting the Liver X Receptors for treatment of inflammatory disease , 2018, Pharmacology & therapeutics.